Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence
Arnaud G. L’Huillier, Sabrina Pagano, Stéphanie Baggio, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 10
Open Access | Times Cited: 20

Showing 20 citing articles:

ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
Anthony L. Komaroff, W. Ian Lipkin
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 164
Prevalence and clinical presentation of long COVID in children: a systematic review
Roberta Pellegrino, Elena Chiappini, Amelia Licari, et al.
European Journal of Pediatrics (2022) Vol. 181, Iss. 12, pp. 3995-4009
Open Access | Times Cited: 101
COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences
Felix Scholkmann, Christian-Albrecht May
Pathology - Research and Practice (2023) Vol. 246, pp. 154497-154497
Open Access | Times Cited: 78
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Al Ozonoff, Naresh Doni Jayavelu, Shanshan Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Overview of autoantibodies in COVID‐19 convalescents
Krystyna Dobrowolska, Dorota Zarębska‐Michaluk, Barbara Poniedziałek, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 24
Autoantibodies in COVID-19 survivors with post-COVID symptoms: a systematic review
Kin Israel Notarte, Timothy Hudson David Culasino Carandang, Jacqueline Veronica Velasco, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Is post-COVID syndrome an autoimmune disease?
Juan‐Manuel Anaya, María Herrán, Santiago Beltrán, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 7, pp. 653-666
Closed Access | Times Cited: 31
Autoantibodies as potential prognostic factors for clinical outcomes related to COVID-19: a systematic review of inception prospective cohort studies with GRADE recommendations
Farley Carvalho Araújo, Andre Amaral, Hytalo de Jesus Silva, et al.
Brazilian Journal of Medical and Biological Research (2025) Vol. 58
Open Access
Identification of Putative Serum Autoantibodies Associated with Post-Acute Sequelae of COVID-19 via Comprehensive Protein Array Analysis
Yasuyoshi Hatayama, Kei Miyakawa, Yayoi Kimura, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1751-1751
Open Access
Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children
Nicolas Vuilleumier, Sabrina Pagano, Elsa Lorthe, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Adult Long Coronavirus Disease 2019
Ivette F. Emery, Clifford J. Rosen
Infectious Disease Clinics of North America (2025)
Closed Access
Epstein–Barr virus-acquired immunodeficiency in myalgic encephalomyelitis—Is it present in long COVID?
Manuel Ruiz-Pablos, Bruno Paiva, Aintzane Zabaleta
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: A report of signal index cases and call for targeted research
Kenneth Scheppke, Paul E. Pepe, Jonathan Jui, et al.
The American Journal of Emergency Medicine (2023) Vol. 75, pp. 122-127
Open Access | Times Cited: 12
Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms
Abbas F. Almulla, Michaël Maes, Bo Zhou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 12
Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms
Abbas F. Almulla, Michaël Maes, Bo Zhou, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 1
Impact of Long-COVID on Health Care Burden: A Case Control Study
Bernardo Valdivieso, Inmaculada Saurí, Juliette Philibert, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 5768-5768
Open Access | Times Cited: 4
Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms
Abbas F. Almulla, Michaël Maes, Bo Zhou, et al.
Research Square (Research Square) (2024)
Open Access
Impact of Long SARS-CoV-2 Omicron on Health Care Burden: A Case-control Comparative Study with the Pre-Omicron Waves (Preprint)
Bernardo Valdivieso, Victoria López-Sánchez, Inmaculada Saurí, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e53580-e53580
Open Access
Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases
Céline Lamacchia, Denis Mongin, Catherine Juillard, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
Impact of Long SARS-CoV-2 Omicron Infection on the Health Care Burden: Comparative Case-Control Study Between Omicron and Pre-Omicron Waves (Preprint)
Bernardo Valdivieso, Victoria Lopez-Sanchez, Inmaculada Saurí, et al.
(2023)
Closed Access
Page 1

Scroll to top